Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States

Abstract

Although a high‐resolution computed tomography (HRCT) scan of the chest is the gold standard test for the detection of interstitial lung disease (ILD), there is no consensus among rheumatologists regarding the use of HRCT to screen for ILD in their patients with systemic sclerosis (SSc). The aims of this study were to describe the HRCT ordering practices at SSc centers in the United States and to determine which patient characteristics are associated with HRCT performance.

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 23, 2022
Source ID
10.1002/acr2.11434

Entities

People

  • Ami A Shah
  • Brian A. Skaug
  • Chase Correia
  • Dinesh Khanna
  • Elana J Bernstein
  • Faye N. Hant
  • Flavia V Castelino
  • Jessica K Gordon
  • Laura K. Hummers
  • Lorinda Chung
  • Luke B. Evnin
  • Nora Sandorfi
  • Shervin Assassi
  • Tracy M Frech
  • Victoria K Shanmugam
  • Virginia D. Steen

Organizations

  • Columbia University
  • George Washington University
  • Georgetown University
  • Hospital for Special Surgery
  • Johns Hopkins University
  • Massachusetts General Hospital
  • Medical University of South Carolina
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Northwestern University
  • Scleroderma Research Foundation
  • Stanford University
  • United States Department of Defense
  • University of Michigan
  • University of Pennsylvania
  • University of Texas at Austin
  • University of Utah

Tags

Fields of Study

  • Medicine

Readers

  • Immunology and Pathology
  • Oncology and Biomarker-Based Cancer Detection.
  • Trauma or Military Medicine